Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox for Empty Nose Syndrome
NCT00732680Phase 2Terminated
- Sponsor
- Mayo Clinic
- Start
- Dec 2008
- Primary completion
- Nov 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in Empty nose syndrome (ENS), sponsored by Mayo Clinic. Started Dec 2008; status: terminated.
02
Drugs
botulinum toxin type A
03
Conditions
Empty nose syndrome (ENS)
Beyond the preview
Go deeper on NCT00732680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00732680.